Publication date: Jul 07, 2026
Hyperglycemia has increasingly been recognized among individuals recovering from coronavirus disease 2019 (COVID-19); the host factors contributing to heterogeneous metabolic outcomes remain poorly understood. This cohort study investigated the association between innate immune genetic polymorphisms and hyperglycemia in post-COVID-19 patients. A total of 471 adults with previous mild-to-moderate COVID-19 were enrolled through the post-COVID follow-up program at Siriraj Hospital, Thailand, and classified as normoglycemic (HbA1c
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | Hyperglycemia |
| disease | MESH | Obesity |
| disease | MESH | inflammation |
| drug | DRUGBANK | Methyl isocyanate |
| disease | MESH | Genetic Predisposition to Disease |
| drug | DRUGBANK | Nitric Oxide |
Original Article
(Visited 1 times, 1 visits today)